Has Charles Crawford, MD received payments from drug or device companies?

Yes. Drug and device makers reported $836,096 in general payments to Charles Crawford, MD across 371 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Crawford, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Crawford, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Crawford, MD

Orthopaedic Surgery of the Spine · Louisville, KYNPI 1265570808

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $542,398 of the $836,096 with a category attached, or 64.9%. 11 manufacturers reported payments, led by Medtronic at 51.4% of the total. 2025 is the largest year on record at $241,205, 4.2 times the $57,472 reported in 2019.

$836,096in general payments, 2019–2025

Across 371 payments — averaging $2253.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$430K
Globus Medical$323K
Alphatec Spine, Inc$59K
Expanding Innovations, Inc.$19K
Si-bone, Inc.$4K
Stryker$436
plus $542 from 5 others

$18,897in ownership & investment interests, 2019–2025

Across 2 payments — averaging $9448.40 each. An ownership or investment interest held by the physician or an immediate family member.

Expanding Innovations, Inc.$19K

What the payments were for

Royalty or licence$542,39865%
Consulting fees$192,18623%
Speaking & faculty fees$57,3007%
Travel & lodging$34,4764%
Food & beverage$9,7371%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	260	$430,153
Globus Medical(2 entities)	83	$322,986
Alphatec Spine, Inc	7	$59,304
Expanding Innovations, Inc.	4	$19,054
Si-bone, Inc.	9	$3,621
Stryker	3	$436
EBI, LLC	1	$146
Medacta USA, Inc.	1	$125
Bioventus LLC	1	$115
Johnson & Johnson	1	$95
Surgalign Spine Technologies, Inc.	1	$61

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Modulus$289,967
Arsenal Deformity$59,107
CD HORIZON$41,309
INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM$36,283
Arsenal Degen$31,569
ALIF$31,274
Arsenal Degenerative$27,539
CD HORIZON SPINAL SYSTEM$25,126
INFUSE BONE GRAFT$21,023
X-PAC$19,054
TLIF$14,965
GRAFTON$14,311
GRAFTONAND GRAFTON PLUSDEMINERALIZED BONE MATRIX (DBM)$12,755
Adaptix$7,601
INFUSE$7,319
Cervicothoracic - No Product Name Yet$3,900
CAPSTONE$3,378
IFUSE IMPLANT SYSTEM$3,215
MASTERGRAFT$2,252
Pulse$1,511

How this compares

$836,096 in reported general payments places this provider in the 80th percentile of 29 orthopaedic surgery of the spine providers in Kentucky.

See all orthopaedic surgery of the spine providers in Kentucky →

Medicare billing

Part B allowed, 2024

$350,895

Medicare patients

282

Services billed

1,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	54	$707
Gabapentin	46	$368
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	35	$321
Baclofen	20	$111
Tizanidine Hcl	17	$78

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Louisville

Jeffery GumLouisville$3.5M
Mladen DjurasovicLouisville$3.1M
Roger OwensLouisville$1.3M
Joseph LarattaLouisville$819K
Venu VemuriLouisville$796K
Kathryn McCarthy MulloolyLouisville$426K
John DimarLouisville$266K
Steven GlassmanLouisville$249K
John JohnsonLouisville$247K
Mitchell CampbellLouisville$212K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →